Encore: Episode 2 November 9th Annual 2021 C. diff. Conference
Update: 2022-07-26
Description
This is a wonderful opportunity to listen and learn from world-renown
topic leaders from the 9th Annual International C. diff. Conference & Health EXPO
November 4-5, 2021.
Episode 2
“The Burden of Clostridioides difficile Infection In the COVID-19 Era”
Nicola Petrosillo (Speaker) Head Infection Control and Infectious Disease Service, University Hospital Campus Bio-Medico, Rome, Italy
**
Results from ECOSPOR III, a Phase 3 Placebo-Controlled Trial of SER-109, an Investigational Microbiome Therapeutic to Reduce Recurrence of Clostridioides difficile Infection
Barbara McGovern, MD (Speaker) VP, Medical Affairs, Seres Therapeutics
**
Evidence-Based Hand Hygiene In the Post-COVID World.”
Tamas Haidegger (Speaker) Associate Professor, Óbuda University
**
We thank ACURX Pharmaceuticals for being the Audio Sponsor of the
9th Annual Int'l C. diff. Conference & Health EXPO.
topic leaders from the 9th Annual International C. diff. Conference & Health EXPO
November 4-5, 2021.
Episode 2
“The Burden of Clostridioides difficile Infection In the COVID-19 Era”
Nicola Petrosillo (Speaker) Head Infection Control and Infectious Disease Service, University Hospital Campus Bio-Medico, Rome, Italy
**
Results from ECOSPOR III, a Phase 3 Placebo-Controlled Trial of SER-109, an Investigational Microbiome Therapeutic to Reduce Recurrence of Clostridioides difficile Infection
Barbara McGovern, MD (Speaker) VP, Medical Affairs, Seres Therapeutics
**
Evidence-Based Hand Hygiene In the Post-COVID World.”
Tamas Haidegger (Speaker) Associate Professor, Óbuda University
**
We thank ACURX Pharmaceuticals for being the Audio Sponsor of the
9th Annual Int'l C. diff. Conference & Health EXPO.
Comments
In Channel
Download from Google Play
Download from App Store
United States00:00
00:00
1.0x
